Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals - ECDC PPS validation protocol version 3.1.2.
This protocol version is an accompanying document to the ECDC protocol for the point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals version 5.3.
Antimicrobial use in European acute care hospitals: results from the second point prevalence survey (PPS) of healthcare-associated infections and antimicrobial use, 2016 to 2017
Plachouras, D., Kärki, T., Hansen, S., Hopkins, S., Lyytikäinen, O., Moro, M.L., Reilly, J., Zarb, P., Zingg, W., Kinross, P., Weist, K., Monnet, D.L., Suetens, C., The Point Prevalence Survey Study Group
Antimicrobial use in European long-term care facilities: results from the third point prevalence survey of healthcare-associated infections and antimicrobial use, 2016 to 2017
Ricchizzi, E., Latour, K., Kärki, T., Buttazzi, R., Jans, B., Moro, M.L., Nakitanda, O.A., Plachouras, D., Monnet, D.L., Suetens, C., Kinross, P., The Halt Study Group
Prevalence of healthcare-associated infections, estimated incidence and composite antimicrobial resistance index in acute care hospitals and long-term care facilities: results from two European point prevalence surveys, 2016 to 2017
Suetens, C., Latour, K., Kärki, T., Ricchizzi, E., Kinross, P., Moro, M.L., Jans, B., Hopkins, S., Hansen, S., Lyytikäinen, O., Reilly, J., Deptula, A., Zingg, W., Plachouras, D., Monnet, D.L., The Healthcare-Associated Infections Prevalence Study Group
Healthcare-associated pneumonia in acute care hospitals in European union/European economic area countries: An analysis of data from a point prevalence survey, 2011 to 2012
Walter, J., Haller, S., Quinten, C., Kärki, T., Zacher, B., Eckmanns, T., Abu Sin, M., Plachouras, D., Kinross, P., Suetens, C., Strauss, R., Mertens, K., Dobreva, E., Budimir, A., Hadjiloucas, A., Prattingerová, J., Kristensen, B., Monnet, D.L., Märtin, P., Lyytikäinen, O., Giard, M., Piening, B., Kritsotakis, E.I., Kurcz, A., Gudlaugsson, Ó., Burns, K., Moro, M.L., Dumpis, U., Ašembergienė, J., Heisbourg, E., Xuereb, D., Hopmans, T., Sorknes, N.K., Deptuła, A., Paiva, J.-A., Serban, R., Litvová, S., Kolman, J., Lozano, J., Struwe, J., Hopkins, S., Doherty, L., Reilly, J.S., Harrison, W.
Rapid risk assessment: Carbapenemase-producing (OXA-48) Klebsiella pneumoniae ST392 in travellers previously hospitalised in Gran Canaria, Spain
This rapid risk assessment evaluates the risk of transmission and further spread of OXA-48-producing Klebsiella pneumonia e ST392 from travellers having sought medical care in Gran Canaria to healthcare facilities in their country of origin in the EU/EEA.
Rapid risk assessment: Emergence of resistance to ceftazidime-avibactam in carbapenem-resistant Enterobacteriaceae
This risk assessment will discuss CAZ-AVI resistance in brief, review the recent literature reporting resistance of CRE to CAZ-AVI, and assess the risk for the EU/EEA countries.
Rapid risk assessment: Carbapenem-resistant Enterobacteriaceae - first update
This update of the 2016 ECDC Rapid Risk Assessment on carbapenem-resistant Enterobacteriaceae (CRE) evaluates the risk for patients and healthcare systems in EU/EEA countries due to the global spread of CRE.
Healthcare-associated infections in intensive care units - Annual Epidemiological Report for 2016
This report is based on data for 2016 retrieved from The European Surveillance System (TESSy) on 26 April 2018. TESSy is a system for the collection, analysis and dissemination of data on communicable diseases. EU Member States and EEA countries contribute to the system by uploading their infectious disease surveillance data at regular intervals.